Результаты поиска

Invited Lectures : Overviews Purinergic signalling: past, present and future.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Viral warfare: unleashing engineered oncolytic viruses to outsmart cancer's defenses.

Oncolytic virotherapy (OVT) has emerged as a promising and innovative cancer treatment strategy that harnesses engineered viruses to selectively infect, replicate within, and destroys malignant cells while sparing healthy tissues. Beyond direct oncolysis, oncolytic viruses (OVs) exploit tumor-specific metabolic, antiviral, and immunological vulnerabilities to reshape the tumor microenvironment (TME) and initiate systemic antitumor immunity. Despite promising results from preclinical and clinical studies, several barriers, including inefficient intratumoral virus delivery, immune clearance, and

Surfactant-Enabled Nanocarriers in Breast Cancer Therapy: Targeted Delivery and Multidrug Resistance Reversal.

Breast cancer remains a leading cause of cancer-related morbidity and mortality among women worldwide. Its treatment is complicated by molecular heterogeneity and the frequent development of multidrug resistance (MDR). Conventional drug delivery approaches are often limited by poor aqueous solubility, rapid systemic clearance, non-specific biodistribution, and off-target toxicity. This review will critically explore the possibility of surfactant-based drug delivery systems (DDSs) in addressing the constraints of standard breast cancer treatments. It focuses on the mechanisms by which surfactan

Совпадение в полном тексте источника
… Anticancer treatment | [ 71 ] Mixed Pluronic micelles | Paclitaxel | Treatment of multidrug-resistant tumors | Enhanced permeability and retention (EPR) effect | Overcoming drug resistance | [ 73 ] Thermoreversible Pluronic ® F127 hydrogel (Modular Compact Rheometer (MCR 302), Anton Paar GmbH, Graz, Austria …

Abstract Book for the 3rd European Myeloma Network Meeting

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Совпадение в полном тексте источника
… COVID-19 AND MYELOMA H Ludwig; P Sonneveld; M Boccadoro; E Terpos; - European Multiple Myeloma Network (EMN) Wilhelminen Cancer Research Institute, First Department of Medicine, Center for Oncology, Hematology, and Palliative Care, Clinic Ottakring, Vienna, Austria; Erasmus MC Cancer Institute & Erasmus …

Childhood Cancer: Occurrence, Treatment and Risk of Second Primary Malignancies.

Cancer represents the leading cause of disease-related death and treatment-associated morbidity in children with an increasing trend in recent decades worldwide. Nevertheless, the 5-year survival of childhood cancer patients has been raised impressively to more than 80% during the past decades, primarily attributed to improved diagnostic technologies and multiagent cytotoxic regimens. This strong benefit of more efficient tumor control and prolonged survival is compromised by an increased risk of adverse and fatal late sequelae. Long-term survivors of pediatric tumors are at the utmost risk fo

Abstracts cont.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Резюме: 32 Второй Конгресс ЭСП и Международный конгресс XXXIII МПД.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

49th ESCP virtual symposium on clinical pharmacy 19.10.2021-21.10.2021 Clinical pharmacy, working collaboratively in mental health care.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

RESEARCH COMMUNICATIONS OF THE 28th ECVIM-CA CONGRESS.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Ход работы сессии 29th Европейский конгресс педиатрии.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Совпадение в полном тексте источника
… Einrichtungen der Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany; 18 Kinder- und Jugendheilkunde, Medizinische Universität Innsbruck, Innsbruck, Austria, 19 Kinderklinik - Rheumaambulanz, Medizinische Hochschule Hannover, Hannover; 20 Klinik für Kinder- und Jugendmedizin, Clementine Kinderhospital … Anna Children’s Cancer Research Institute , Vienna, Austria; 5 Department of Clinical Chemistry, Amsterdam UMC location University of Amsterdam, Amsterdam, Netherlands Correspondence: J. …

36th International Symposium on Intensive Care and Emergency Medicine : Brussels, Belgium. 15-18 March 2016.

P001 - Sepsis impairs the capillary response within hypoxic capillaries and decreases erythrocyte oxygen-dependent ATP efflux R. M. Bateman, M. D. Sharpe, J. E. Jagger, C. G. Ellis P002 - Lower serum immunoglobulin G2 level does not predispose to severe flu. J. Solé-Violán, M. López-Rodríguez, E. Herrera-Ramos, J. Ruíz-Hernández, L. Borderías, J. Horcajada, N. González-Quevedo, O. Rajas, M. Briones, F. Rodríguez de Castro, C. Rodríguez Gallego P003 - Brain protective effects of intravenous immunoglobulin through inhibition of complement activation and apoptosis in a rat model of sepsis F. Esen

Antiaging Strategies and Remedies: A Landscape of Research Progress and Promise.

Aging is typified by a gradual loss of physiological fitness and accumulation of cellular damage, leading to deteriorated functions and enhanced vulnerability to diseases. Antiaging research has a long history throughout civilization, with many efforts put forth to understand and prevent the effects of aging. Multiple strategies aiming to promote healthy aging and extend the lifespan have been developed including lifestyle adjustments, medical treatments, and social programs. A multitude of antiaging medicines and remedies have also been explored. Here, we use data from the CAS Content Collect

Совпадение в полном тексте источника
… abbreviations on the right indicate the patent offices of China (CN), Korea (KR), Israel (IL), Hong Kong (HK), Argentina (AR), Australia (AU), Russian Federation (RU), United States (US), World Intellectual Property Organization (WO), Taiwan (TW), Mexico (MX), Japan (JP), Canada (CA), Brazil (BR), Austria …

Обязательный экзамен по патологии: лишний или необходимый?

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Oral Presentations

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Antibodies to watch in 2023.

In this 14th installment of the annual Antibodies to Watch article series, we discuss key events in commercial monoclonal antibody therapeutics development that occurred in 2022 and forecast events that might occur in 2023. As of mid-November, 12 antibody therapeutics had been granted first approvals in either the United States or European Union (tebentafusp (Kimmtrak), faricimab (Vabysmo), sutimlimab (Enjaymo), relatlimab (Opdualag), tixagevimab/cilgavimab (Evusheld), mosunetuzumab (Lunsumio), teclistamab (TECVAYLI), spesolimab (SPEVIGO), tremelimumab (Imjudo; combo with durvalumab), nirsevim

Proceedings of the Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting 2018

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Совпадение в полном тексте источника
… Kruse 1 , Glenis Scadding 4 1 ALK, Horsholm, Denmark; 2 Allergy Outpatient Clinic, Rennweg, Vienna, Austria; 3 ALK, Bedminster, NJ, United States; 4 Department of Allergy and Medical Rhinology, Royal National Throat, Nose and Ear Hospital, London, United Kingdom Correspondence: Marianne Witten Allergy …

ICAR 2011. Italian Conference on AIDS and Retroviruses, Florence, Italy, 27-29 March 2011. Abstracts.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Oral Presentations

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

The International Headache Congress - IHS and EHF joint congress 2021 : Virtual. 8-12 September 2021.

Аннотация не предоставлена источником. Откройте карточку для перехода к публикации.

Human papillomavirus (HPV) vaccination for the prevention of cervical cancer and other HPV-related diseases: a network meta-analysis.

BACKGROUND: Cervical cancer is the fourth most common cause of cancer-related death amongst females worldwide. Persistent infection with high-risk human papillomavirus (HPV) is the key factor in cervical cancer development. HPV vaccines aim to prevent cancer by generating antibodies against HPV infection. OBJECTIVES: To evaluate the safety and efficacy of HPV vaccines, in females and males, to prevent cervical cancer and other HPV-related diseases, in standard (pairwise) and network meta-analysis (NMA) of randomised controlled trials. SEARCH METHODS: On 10 January 2022, we searched the Cochr